SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-056557
Filing Date
2018-09-13
Accepted
2018-09-13 08:28:50
Documents
2
Period of Report
2018-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-28092_18k.htm 8-K 28875
2 EX-99.1 a18-28092_1ex99d1.htm EX-99.1 10394
  Complete submission text file 0001104659-18-056557.txt   40389
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 181067997
SIC: 2834 Pharmaceutical Preparations